Comparison of Autologous Conditioned Serum and Platelet‐Rich Plasma Following Arthrocentesis in Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial
Journal of Oral Rehabilitation · 2026-12 · 53 (12) · 2414-2423
DOI: 10.1111/joor.70314 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Rehabilitation, online erschienen am 24.09.2026. Verfasst von Rojdan Ferman Güneş Uysal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Batman University, Batman, Türkiye. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Arthrocentesis, Temporomandibular Joint Disorders, Osteoarthritis. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Temporomandibular joint osteoarthritis (TMJ‐OA) is a degenerative condition that negatively affects quality of life. Although platelet‐rich plasma (PRP) is widely used, its efficacy remains controversial. Autologous conditioned serum (ACS), which targets inflammation via interleukin‐1 receptor antagonist (IL‐1Ra), has emerged as a novel biological therapy.
Objective
To compare the effects of two autologous biological agents, PRP and ACS, used as adjuncts to arthrocentesis, on pain, maximum mouth opening (MMO) and joint sounds in patients with TMJ‐OA.
Methods
This randomized, single‐centre clinical trial with blinded outcome assessment and statistical analysis included 75 patients with TMJ‐OA. Participants were allocated to three groups: ACS, PRP and control ( n = 25 each). All patients underwent arthrocentesis; the ACS and PRP groups received 1 mL intra‐articular injections, while the control group received no additional treatment. Outcomes were assessed at baseline, 1 week, 1 month, 3 months and 6 months by a blinded assessor. Pain was evaluated using a visual analogue scale (VAS), MMO was measured in millimetres and joint sounds were clinically assessed.
Results
Baseline characteristics were comparable among the groups. From the first week onward, significant differences in VAS and MMO were observed at all follow‐up time points ( p < 0.001). Both ACS and PRP groups demonstrated greater improvement compared to the control group. However, no consistent statistically significant differences were observed between the two treatment groups. Joint sounds decreased significantly in both treatment groups, particularly at later follow‐up periods.
Conclusion
Both ACS and PRP following arthrocentesis improved clinical outcomes in TMJ‐OA, with no consistent superiority between treatments. Trial Registration ClinicalTrials.gov : NCT06839326
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Batman University, Batman, Türkiye.
- Department of Endodontics, Faculty of Dentistry, Dicle University, Diyarbakır, Türkiye.
ORCID-Profile: Rojdan Ferman Güneş Uysal, Ibrahim Uysal
Zitieren
APA
Uysal, R. F. G., & Uysal, I. (2026). Comparison of Autologous Conditioned Serum and Platelet‐Rich Plasma Following Arthrocentesis in Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial. Journal of Oral Rehabilitation, 53(12), 2414-2423. https://doi.org/10.1111/joor.70314
Vancouver
Uysal RFG, Uysal I. Comparison of Autologous Conditioned Serum and Platelet‐Rich Plasma Following Arthrocentesis in Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial. Journal of Oral Rehabilitation. 2026;53(12):2414-2423. doi:10.1111/joor.70314
BibTeX
@article{Uysal2026,
author = {Uysal, Rojdan Ferman Güneş and Uysal, Ibrahim},
title = {Comparison of Autologous Conditioned Serum and Platelet‐Rich Plasma Following Arthrocentesis in Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial},
journal = {Journal of Oral Rehabilitation},
year = {2026},
volume = {53},
number = {12},
pages = {2414--2423},
doi = {10.1111/joor.70314}
}
EUVIMED